Symbols / SKIN Stock $0.67 +2.09% SkinHealth Systems Inc.

Consumer Defensive • Household & Personal Products • United States • NCM
SKIN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Consumer Defensive
Industry Household & Personal Products
CEO Mr. Pedro Malha
Exch · Country NCM · United States
Market Cap 86.61M
Enterprise Value 249.61M
Income -6.54M
Sales 296.12M
FCF (ttm) 28.42M
Book/sh 0.48
Cash/sh 1.56
Employees 613
Insider 10d —
IPO Nov 24, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -33.41
PEG 0.93
P/S 0.29
P/B 1.40
P/C —
EV/EBITDA 17.91
EV/Sales 0.84
Quick Ratio 1.43
Current Ratio 1.79
Debt/Eq 664.61
LT Debt/Eq —
EPS (ttm) -0.13
EPS next Y -0.02
EPS Growth —
Revenue Growth -6.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-07
ROA -1.15%
ROE -11.95%
ROIC —
Gross Margin 64.91%
Oper. Margin -2.77%
Profit Margin -2.04%
Shs Outstand 129.60M
Shs Float 65.01M
Insider Own 13.19%
Instit Own 89.13%
Short Float 35.43%
Short Ratio 26.01
Short Interest 16.53M
52W High 2.69
vs 52W High -75.16%
52W Low 0.55
vs 52W Low 21.29%
Beta 1.12
Impl. Vol. 4.25%
Rel Volume 1.09
Avg Volume 905.17K
Volume 984.28K
Target (mean) $1.51
Tgt Median $1.27
Tgt Low $1.00
Tgt High $2.50
# Analysts 6
Recom Hold
Prev Close $0.65
Price $0.67
Change 2.09%
About

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$1.51
Mean price target
2. Current target
$0.67
Latest analyst target
3. DCF / Fair value
$3.95
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.67
Low
$1.00
High
$2.50
Mean
$1.51

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-01 main Canaccord Genuity Hold → Hold $1
2026-03-16 main TD Cowen Hold → Hold $2
2026-03-13 main Canaccord Genuity Hold → Hold $2
2026-01-21 main TD Cowen Hold → Hold $2
2025-09-22 main TD Cowen Hold → Hold $3
2025-09-19 init Roth Capital — → Buy $4
2025-05-05 main Canaccord Genuity Hold → Hold $1
2025-03-13 main Canaccord Genuity Hold → Hold $2
2024-11-13 main Canaccord Genuity Hold → Hold $2
2024-08-12 main Canaccord Genuity Hold → Hold $1
2024-08-09 reit Piper Sandler Underweight → Underweight $1
2024-07-26 main Stifel Hold → Hold $2
2024-07-11 main Piper Sandler Underweight → Underweight $2
2024-05-13 main DA Davidson Buy → Buy $5
2024-05-13 main TD Cowen Hold → Hold $3
2024-05-10 main Piper Sandler Underweight → Underweight $3
2024-03-15 main DA Davidson Buy → Buy $5
2024-03-14 main Canaccord Genuity Hold → Hold $4
2024-03-13 reit Stifel Hold → Hold $4
2024-03-13 main TD Cowen Market Perform → Market Perform $4
News
RSS: Latest SKIN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-20 MONAHAN MICHAEL P Chief Financial Officer — 746,681 $0.00 $0
2026-03-20 MENEZES RONALD Officer — 746,681 $0.00 $0
2026-03-20 LEWIS SHERI Chief Operating Officer — 746,681 $0.00 $0
2026-03-20 MALHA PEDRO BRUNO FERREIRA Chief Executive Officer — 2,654,867 $0.00 $0
2025-11-13 SCHAISON PHILIPPE Director — 57,692 $0.00 $0
2025-10-09 MALHA PEDRO BRUNO FERREIRA Chief Executive Officer — 2,190,384 $1.56 $3,416,999
2025-06-16 FANNING STEPHEN J Director — 73,051 $0.00 $0
2025-06-16 SAUNDERS BRENT L. Chairman of the Board — 73,051 $0.00 $0
2025-06-16 KERRICK MICHELLE C. Director — 73,051 $0.00 $0
2025-06-16 GRUBER DESIREE Director — 73,051 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
300.79
-10.02%
334.29
-16.00%
397.99
+8.78%
365.88
Operating Revenue
300.79
-10.02%
334.29
-16.00%
397.99
+8.78%
365.88
Cost Of Revenue
104.43
-31.30%
152.00
-37.42%
242.88
+107.42%
117.10
Reconciled Cost Of Revenue
104.43
-31.30%
152.00
-37.42%
242.88
+107.42%
117.10
Gross Profit
196.36
+7.72%
182.30
+17.52%
155.11
-37.65%
248.78
Operating Expense
217.17
-13.16%
250.07
-12.57%
286.03
+4.15%
274.62
Research And Development
5.63
-10.61%
6.30
-37.68%
10.10
+19.64%
8.44
Selling General And Administration
211.54
-13.22%
243.77
-11.65%
275.93
+3.66%
266.18
Selling And Marketing Expense
93.59
-20.89%
118.31
-18.12%
144.50
-9.73%
160.08
General And Administrative Expense
117.95
-5.99%
125.46
-4.54%
131.43
+23.88%
106.10
Other Gand A
117.95
-5.99%
125.46
-4.54%
131.43
+23.88%
106.10
Total Expenses
321.59
-20.02%
402.07
-23.98%
528.91
+35.02%
391.72
Operating Income
-20.80
+69.31%
-67.77
+48.23%
-130.92
-406.63%
-25.84
Total Operating Income As Reported
-20.80
+69.31%
-67.77
+48.23%
-130.92
-406.63%
-25.84
EBITDA
38.74
+166.38%
14.54
+127.15%
-53.56
-165.64%
81.60
Normalized EBITDA
32.43
+101.27%
16.11
+123.74%
-67.87
-1589.34%
4.56
Reconciled Depreciation
25.35
-24.74%
33.68
-2.87%
34.67
+51.60%
22.87
EBIT
13.39
+169.96%
-19.14
+78.31%
-88.24
-250.24%
58.73
Total Unusual Items
6.31
+501.40%
-1.57
-110.98%
14.30
-81.43%
77.05
Total Unusual Items Excluding Goodwill
6.31
+501.40%
-1.57
-110.98%
14.30
-81.43%
77.05
Net Income
-9.52
+67.29%
-29.10
+70.94%
-100.12
-326.38%
44.22
Pretax Income
-5.94
+79.91%
-29.55
+71.00%
-101.89
-324.73%
45.34
Net Non Operating Interest Income Expense
-10.37
-266.43%
6.23
-34.57%
9.52
+325.85%
-4.22
Interest Expense Non Operating
19.33
+85.61%
10.41
-23.72%
13.65
+1.92%
13.39
Net Interest Income
-10.37
-266.43%
6.23
-34.57%
9.52
+325.85%
-4.22
Interest Expense
19.33
+85.61%
10.41
-23.72%
13.65
+1.92%
13.39
Interest Income Non Operating
8.95
-46.20%
16.64
-28.18%
23.17
+152.57%
9.18
Interest Income
8.95
-46.20%
16.64
-28.18%
23.17
+152.57%
9.18
Other Income Expense
25.24
-21.11%
31.99
+64.03%
19.50
-74.13%
75.40
Other Non Operating Income Expenses
18.93
-43.60%
33.56
+545.44%
5.20
+415.15%
-1.65
Gain On Sale Of Security
6.31
+501.40%
-1.57
-110.98%
14.30
-81.43%
77.05
Tax Provision
3.58
+892.26%
-0.45
+74.51%
-1.77
-259.01%
1.11
Tax Rate For Calcs
0.00
+1300.00%
0.00
-13.80%
0.00
-27.50%
0.00
Tax Effect Of Unusual Items
1.32
+5719.61%
-0.02
-109.47%
0.25
-86.54%
1.85
Net Income Including Noncontrolling Interests
-9.52
+67.29%
-29.10
+70.94%
-100.12
-326.38%
44.22
Net Income From Continuing Operation Net Minority Interest
-9.52
+67.29%
-29.10
+70.94%
-100.12
-326.38%
44.22
Net Income From Continuing And Discontinued Operation
-9.52
+67.29%
-29.10
+70.94%
-100.12
-326.38%
44.22
Net Income Continuous Operations
-9.52
+67.29%
-29.10
+70.94%
-100.12
-326.38%
44.22
Normalized Income
-14.50
+47.37%
-27.55
+75.87%
-114.17
-268.60%
-30.97
Net Income Common Stockholders
-9.52
+67.29%
-29.10
+70.94%
-100.12
-326.38%
44.22
Diluted EPS
-0.16
+30.43%
-0.23
+69.74%
-0.76
-430.43%
0.23
Basic EPS
-0.08
+65.22%
-0.23
+69.74%
-0.76
-353.33%
0.30
Basic Average Shares
126.38
+2.06%
123.83
-5.96%
131.68
-10.76%
147.55
Diluted Average Shares
135.80
+9.67%
123.83
-5.96%
131.68
-11.33%
148.51
Diluted NI Availto Com Stockholders
-22.11
+57.29%
-51.77
+48.29%
-100.12
-193.43%
-34.12
Average Dilution Earnings
-12.59
+44.47%
-22.67
0.00
+100.00%
-78.34
Line Item Trend 2023-12-31
Total Assets
929.11
Current Assets
698.25
Cash Cash Equivalents And Short Term Investments
523.02
Cash And Cash Equivalents
523.02
Receivables
55.03
Accounts Receivable
54.70
Gross Accounts Receivable
61.30
Allowance For Doubtful Accounts Receivable
-6.60
Taxes Receivable
0.33
Inventory
91.32
Raw Materials
24.41
Finished Goods
66.92
Prepaid Assets
—
Other Current Assets
28.88
Total Non Current Assets
230.86
Net PPE
26.35
Gross PPE
46.30
Accumulated Depreciation
-19.95
Properties
0.00
Machinery Furniture Equipment
20.22
Construction In Progress
0.75
Other Properties
13.01
Leases
12.32
Goodwill And Other Intangible Assets
187.94
Goodwill
125.82
Other Intangible Assets
62.12
Non Current Deferred Assets
0.53
Non Current Deferred Taxes Assets
0.53
Other Non Current Assets
16.04
Total Liabilities Net Minority Interest
869.72
Current Liabilities
115.01
Payables And Accrued Expenses
84.95
Payables
62.96
Accounts Payable
44.77
Other Payable
—
Current Accrued Expenses
21.99
Pensionand Other Post Retirement Benefit Plans Current
4.00
Total Tax Payable
18.19
Income Tax Payable
2.76
Current Debt And Capital Lease Obligation
4.60
Current Debt
—
Other Current Borrowings
—
Current Capital Lease Obligation
4.60
Current Deferred Liabilities
0.45
Current Deferred Revenue
0.45
Total Non Current Liabilities Net Minority Interest
754.72
Long Term Debt And Capital Lease Obligation
747.69
Long Term Debt
738.37
Long Term Capital Lease Obligation
9.32
Non Current Deferred Liabilities
0.70
Non Current Deferred Taxes Liabilities
0.70
Other Non Current Liabilities
2.77
Stockholders Equity
59.39
Common Stock Equity
59.39
Capital Stock
0.01
Common Stock
0.01
Preferred Stock
—
Share Issued
122.90
Ordinary Shares Number
122.90
Treasury Shares Number
0.00
Additional Paid In Capital
541.28
Retained Earnings
-478.87
Gains Losses Not Affecting Retained Earnings
-3.04
Other Equity Adjustments
-3.04
Total Equity Gross Minority Interest
59.39
Total Capitalization
797.76
Working Capital
583.24
Invested Capital
797.76
Total Debt
752.29
Net Debt
215.35
Capital Lease Obligations
13.92
Net Tangible Assets
-128.55
Tangible Book Value
-128.55
Current Provisions
21.01
Derivative Product Liabilities
3.56
Interest Payable
2.34
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
37.48
+132.34%
16.13
-25.82%
21.75
+120.40%
-106.60
Cash Flow From Continuing Operating Activities
37.48
+132.34%
16.13
-25.82%
21.75
+120.40%
-106.60
Net Income From Continuing Operations
-9.52
+67.29%
-29.10
+70.94%
-100.12
-326.38%
44.22
Depreciation Amortization Depletion
25.35
-24.74%
33.68
-2.87%
34.67
+51.60%
22.87
Depreciation
3.85
-61.29%
9.94
-12.28%
11.33
+58.18%
7.16
Amortization Cash Flow
21.50
-9.43%
23.74
+1.70%
23.34
+48.60%
15.71
Depreciation And Amortization
25.35
-24.74%
33.68
-2.87%
34.67
+51.60%
22.87
Amortization Of Intangibles
21.50
-9.43%
23.74
+1.70%
23.34
+48.60%
15.71
Other Non Cash Items
-14.56
-3.18%
-14.11
-224.92%
11.30
-31.29%
16.44
Stock Based Compensation
14.82
-44.47%
26.70
+18.42%
22.54
-20.88%
28.50
Provisionand Write Offof Assets
2.07
-59.74%
5.13
-0.37%
5.15
+217.69%
1.62
Asset Impairment Charge
7.22
-74.26%
28.04
-25.90%
37.84
+635.61%
5.14
Deferred Tax
2.22
+159.20%
-3.75
-247.36%
-1.08
+39.62%
-1.79
Deferred Income Tax
2.22
+159.20%
-3.75
-247.36%
-1.08
+39.62%
-1.79
Operating Gains Losses
-0.49
+84.12%
-3.07
+74.27%
-11.92
+84.79%
-78.34
Gain Loss On Investment Securities
-0.49
+84.12%
-3.07
+74.27%
-11.92
+84.79%
-78.34
Net Foreign Currency Exchange Gain Loss
—
—
—
2.41
Gain Loss On Sale Of PPE
—
—
—
5.24
Change In Working Capital
10.37
+137.87%
-27.39
-217.28%
23.36
+116.08%
-145.27
Change In Receivables
5.16
-75.19%
20.80
+25.93%
16.52
+151.58%
-32.02
Changes In Account Receivables
5.16
-75.19%
20.80
+25.93%
16.52
+151.58%
-32.02
Change In Inventory
15.79
+250.40%
-10.50
+53.57%
-22.62
+73.19%
-84.36
Change In Prepaid Assets
3.42
-77.89%
15.48
+322.69%
-6.95
+49.80%
-13.85
Change In Payables And Accrued Expense
-7.18
+83.60%
-43.78
-199.49%
44.00
+1589.54%
-2.95
Change In Accrued Expense
—
—
26.94
+902.38%
-3.36
Change In Payable
—
—
17.07
+845.95%
1.80
Change In Account Payable
—
—
15.78
+882.75%
1.61
Change In Other Working Capital
-6.83
+27.39%
-9.40
-23.73%
-7.60
+37.10%
-12.08
Change In Other Current Assets
—
—
—
-8.04
Change In Other Current Liabilities
—
—
—
-4.03
Investing Cash Flow
-5.16
+24.01%
-6.79
+78.44%
-31.51
-66.98%
-18.87
Cash Flow From Continuing Investing Activities
-5.16
+24.01%
-6.79
+78.44%
-31.51
-66.98%
-18.87
Net PPE Purchase And Sale
-0.30
+59.92%
-0.76
+80.24%
-3.83
+64.74%
-10.85
Purchase Of PPE
-0.30
+59.92%
-0.76
+80.24%
-3.83
+64.74%
-10.85
Capital Expenditure
-5.16
+24.01%
-6.79
+47.93%
-13.05
+24.98%
-17.39
Capital Expenditure Reported
—
—
—
-17.39
Net Business Purchase And Sale
—
—
0.00
0.00
Purchase Of Business
—
—
0.00
0.00
Net Intangibles Purchase And Sale
-4.86
+19.51%
-6.04
+34.54%
-9.22
-40.89%
-6.55
Purchase Of Intangibles
-4.86
+19.51%
-6.04
+34.54%
-9.22
-40.89%
-6.55
Net Other Investing Changes
—
—
-18.46
-1151.39%
-1.48
Financing Cash Flow
-174.93
-10.47%
-158.34
-322.83%
-37.45
+81.75%
-205.24
Cash Flow From Continuing Financing Activities
-174.93
-10.47%
-158.34
-322.83%
-37.45
+81.75%
-205.24
Net Issuance Payments Of Debt
-173.35
-11.07%
-156.08
0.00
0.00
Issuance Of Debt
237.60
0.00
0.00
0.00
Repayment Of Debt
-410.95
-163.29%
-156.08
0.00
0.00
Long Term Debt Issuance
237.60
0.00
0.00
0.00
Long Term Debt Payments
-410.95
-163.29%
-156.08
0.00
0.00
Net Long Term Debt Issuance
-173.35
-11.07%
-156.08
0.00
0.00
Short Term Debt Issuance
—
—
0.00
0.00
Short Term Debt Payments
—
—
0.00
0.00
Net Short Term Debt Issuance
—
—
0.00
0.00
Net Common Stock Issuance
0.00
0.00
+100.00%
-32.40
+79.75%
-160.00
Common Stock Payments
0.00
0.00
+100.00%
-32.40
+79.75%
-160.00
Repurchase Of Capital Stock
0.00
0.00
+100.00%
-32.40
+79.75%
-160.00
Proceeds From Stock Option Exercised
—
—
0.00
0.00
Net Other Financing Charges
-1.57
+30.41%
-2.26
+55.29%
-5.05
+88.83%
-45.24
Changes In Cash
-142.60
+4.29%
-149.00
-215.65%
-47.20
+85.73%
-330.71
Effect Of Exchange Rate Changes
5.21
+231.63%
-3.96
-294.84%
2.03
+168.27%
-2.98
Beginning Cash Position
370.06
-29.25%
523.02
-7.95%
568.20
-37.00%
901.89
End Cash Position
232.67
-37.13%
370.06
-29.25%
523.02
-7.95%
568.20
Free Cash Flow
32.32
+246.06%
9.34
+7.34%
8.70
+107.02%
-123.99
Interest Paid Supplemental Data
14.44
+80.18%
8.01
-14.52%
9.38
-4.51%
9.82
Income Tax Paid Supplemental Data
—
2.80
+23.45%
2.27
—
Change In Income Tax Payable
—
—
1.28
+547.47%
0.20
Change In Tax Payable
—
—
1.28
+547.47%
0.20
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category